Alleviation of the mitochondrial dynamics impairment in doxorubicin-induced cardiomyocyte toxicity by cardioprotective agents
Human & Experimental Toxicology
Published online on February 21, 2026
Abstract
Human & Experimental Toxicology, Volume 45, January-December 2026.
PurposeThe cardiotoxic effects of anti-cancer agents on cardiomyocytes are a significant challenge for physicians. The current experiment aims to explore the potential cardioprotective effects of cardiovascular agents, i.e., eplerenone, empagliflozin, and ...
PurposeThe cardiotoxic effects of anti-cancer agents on cardiomyocytes are a significant challenge for physicians. The current experiment aims to explore the potential cardioprotective effects of cardiovascular agents, i.e., eplerenone, empagliflozin, and ...